These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21812332)

  • 1. A toxicological evaluation of a claudin modulator, the C-terminal fragment of Clostridium perfringens enterotoxin, in mice.
    Suzuki H; Kondoh M; Li X; Takahashi A; Matsuhisa K; Matsushita K; Kakamu Y; Yamane S; Kodaka M; Isoda K; Yagi K
    Pharmazie; 2011 Jul; 66(7):543-6. PubMed ID: 21812332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of a mucosal vaccine using the C-terminal fragment of Clostridium perfringens enterotoxin.
    Suzuki H; Kakutani H; Kondoh M; Watari A; Yagi K
    Pharmazie; 2010 Oct; 65(10):766-9. PubMed ID: 21105580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of C-terminal regions of the C-terminal fragment of Clostridium perfringens enterotoxin in its interaction with claudin-4.
    Takahashi A; Kondoh M; Masuyama A; Fujii M; Mizuguchi H; Horiguchi Y; Watanabe Y
    J Control Release; 2005 Nov; 108(1):56-62. PubMed ID: 16091298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution and safety evaluation of a claudin-targeting molecule, the C-terminal fragment of Clostridium perfringens enterotoxin.
    Li X; Saeki R; Watari A; Yagi K; Kondoh M
    Eur J Pharm Sci; 2014 Feb; 52():132-7. PubMed ID: 24231339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of a claudin-targeting molecule using a C-terminal fragment of Clostridium perfringens enterotoxin.
    Ebihara C; Kondoh M; Hasuike N; Harada M; Mizuguchi H; Horiguchi Y; Fujii M; Watanabe Y
    J Pharmacol Exp Ther; 2006 Jan; 316(1):255-60. PubMed ID: 16183701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of an alanine-substituted mutant of the C-terminal fragment of Clostridium perfringens enterotoxin as a mucosal vaccine in mice.
    Suzuki H; Kondoh M; Kakutani H; Yamane S; Uchida H; Hamakubo T; Yagi K
    Biomaterials; 2012 Jan; 33(1):317-24. PubMed ID: 21983135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Tyr306 in the C-terminal fragment of Clostridium perfringens enterotoxin for modulation of tight junction.
    Ebihara C; Kondoh M; Harada M; Fujii M; Mizuguchi H; Tsunoda S; Horiguchi Y; Yagi K; Watanabe Y
    Biochem Pharmacol; 2007 Mar; 73(6):824-30. PubMed ID: 17169334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of N-terminal amino acids in the absorption-enhancing effects of the c-terminal fragment of Clostridium perfringens enterotoxin.
    Masuyama A; Kondoh M; Seguchi H; Takahashi A; Harada M; Fujii M; Mizuguchi H; Horiguchi Y; Watanabe Y
    J Pharmacol Exp Ther; 2005 Aug; 314(2):789-95. PubMed ID: 15870390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutated C-terminal fragments of Clostridium perfringens enterotoxin have increased affinity to claudin-4 and reversibly modulate tight junctions in vitro.
    Takahashi A; Kondoh M; Uchida H; Kakamu Y; Hamakubo T; Yagi K
    Biochem Biophys Res Commun; 2011 Jul; 410(3):466-70. PubMed ID: 21672529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of Clostridium perfringens enterotoxin, by site-directed mutagenesis.
    Takahashi A; Komiya E; Kakutani H; Yoshida T; Fujii M; Horiguchi Y; Mizuguchi H; Tsutsumi Y; Tsunoda S; Koizumi N; Isoda K; Yagi K; Watanabe Y; Kondoh M
    Biochem Pharmacol; 2008 Apr; 75(8):1639-48. PubMed ID: 18342294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier.
    Sonoda N; Furuse M; Sasaki H; Yonemura S; Katahira J; Horiguchi Y; Tsukita S
    J Cell Biol; 1999 Oct; 147(1):195-204. PubMed ID: 10508866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal vaccination using claudin-4-targeting.
    Kakutani H; Kondoh M; Fukasaka M; Suzuki H; Hamakubo T; Yagi K
    Biomaterials; 2010 Jul; 31(20):5463-71. PubMed ID: 20398936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of tyrosine residues in modulation of claudin-4 by the C-terminal fragment of Clostridium perfringens enterotoxin.
    Harada M; Kondoh M; Ebihara C; Takahashi A; Komiya E; Fujii M; Mizuguchi H; Tsunoda S; Horiguchi Y; Yagi K; Watanabe Y
    Biochem Pharmacol; 2007 Jan; 73(2):206-14. PubMed ID: 17097620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel tumor-targeted therapy using a claudin-4-targeting molecule.
    Saeki R; Kondoh M; Kakutani H; Tsunoda S; Mochizuki Y; Hamakubo T; Tsutsumi Y; Horiguchi Y; Yagi K
    Mol Pharmacol; 2009 Oct; 76(4):918-26. PubMed ID: 19638534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creation and biochemical analysis of a broad-specific claudin binder.
    Takahashi A; Saito Y; Kondoh M; Matsushita K; Krug SM; Suzuki H; Tsujino H; Li X; Aoyama H; Matsuhisa K; Uno T; Fromm M; Hamakubo T; Yagi K
    Biomaterials; 2012 Apr; 33(12):3464-74. PubMed ID: 22317861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tight junctions. Structural insight into tight junction disassembly by Clostridium perfringens enterotoxin.
    Saitoh Y; Suzuki H; Tani K; Nishikawa K; Irie K; Ogura Y; Tamura A; Tsukita S; Fujiyoshi Y
    Science; 2015 Feb; 347(6223):775-8. PubMed ID: 25678664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for
    Vecchio AJ; Rathnayake SS; Stroud RM
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific binding of Clostridium perfringens enterotoxin fragment to Claudin-b and modulation of zebrafish epidermal barrier.
    Zhang J; Ni C; Yang Z; Piontek A; Chen H; Wang S; Fan Y; Qin Z; Piontek J
    Exp Dermatol; 2015 Aug; 24(8):605-10. PubMed ID: 25869230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Claudin-4-targeting of diphtheria toxin fragment A using a C-terminal fragment of Clostridium perfringens enterotoxin.
    Kakutani H; Kondoh M; Saeki R; Fujii M; Watanabe Y; Mizuguchi H; Yagi K
    Eur J Pharm Biopharm; 2010 Jun; 75(2):213-7. PubMed ID: 20226859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.
    Maeda T; Murata M; Chiba H; Takasawa A; Tanaka S; Kojima T; Masumori N; Tsukamoto T; Sawada N
    Prostate; 2012 Mar; 72(4):351-60. PubMed ID: 21656836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.